Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

The New England journal of medicine

Volumn 321, Issue 22, 1989, Pages 1506-1510

  Di Bisceglie, A M ^a   Martin, P ^a   Kassianides, C ^a   Lisker Melman, M ^a   Murray, L ^a   Waggoner, J ^a   Goodman, Z ^a   Banks, S M ^a   Hoofnagle, J H ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; RECOMBINANT INTERFERON;

ADULT; ARTICLE; BIOPSY; BLOOD; CHRONIC DISEASE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; LIVER; MALE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VIRUS HEPATITIS;

ADULT; BIOPSY; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; INTERFERON TYPE I, RECOMBINANT; LIVER; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANSAMINASES;

EID: 0024981607     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM198911303212204     Document Type: Article

References (0)